All Relations between Neuromuscular Diseases and dmd

Publication Sentence Publish Date Extraction Date Species
Stephen J P Pratt, Shama R Iyer, Sameer B Shah, Richard M Loverin. Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle. Methods in molecular biology (Clifton, N.J.). vol 1687. 2018-06-05. PMID:29067656. duchenne muscular dystrophy (dmd), caused by the absence of the protein dystrophin, is characterized as a neuromuscular disease in which muscle weakness, increased susceptibility to muscle injury, and inadequate repair appear to underlie the pathology. 2018-06-05 2023-08-13 mouse
Hao Yu, Yu-Chao Chen, Gong-Lu Liu, Zhi-Ying W. A Chinese medical journal. vol 130. issue 19. 2018-05-21. PMID:28937030. a duchenne muscular dystrophy (dmd) and becker muscular dystrophy (bmd) are x-linked recessive neuromuscular diseases resulting from dystrophin (dmd) gene mutations. 2018-05-21 2023-08-13 Not clear
Fazel Shabanpoor, Suzan M Hammond, Frank Abendroth, Gareth Hazell, Matthew J A Wood, Michael J Gai. Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy. Nucleic acid therapeutics. vol 27. issue 3. 2018-05-03. PMID:28118087. splice-switching antisense oligonucleotides are emerging treatments for neuromuscular diseases, with several splice-switching oligonucleotides (ssos) currently undergoing clinical trials such as for duchenne muscular dystrophy (dmd) and spinal muscular atrophy (sma). 2018-05-03 2023-08-13 mouse
I Vieitez, P Gallano, L González-Quereda, S Borrego, I Marcos, J M Millán, T Jairo, C Prior, J Molano, M J Trujillo-Tiebas, J Gallego-Merlo, M García-Barcina, M Fenollar, C Navarr. Mutational spectrum of Duchenne muscular dystrophy in Spain: Study of 284 cases. Neurologia (Barcelona, Spain). vol 32. issue 6. 2018-04-19. PMID:26968818. duchenne muscular dystrophy (dmd) is a severe x-linked recessive neuromuscular disease that affects one in 3500 live-born males. 2018-04-19 2023-08-13 Not clear
Roxanna M Bendixen, Amy Houtro. Parental Reflections on the Diagnostic Process for Duchenne Muscular Dystrophy: A Qualitative Study. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners. vol 31. issue 3. 2018-04-16. PMID:27743907. duchenne muscular dystrophy (dmd) is a rare neuromuscular disease with no known cure. 2018-04-16 2023-08-13 Not clear
Michael P Carver, Jay S Charleston, Courtney Shanks, Jianbo Zhang, Mark Mense, Alok K Sharma, Harjeet Kaur, Peter Sazan. Toxicological Characterization of Exon Skipping Phosphorodiamidate Morpholino Oligomers (PMOs) in Non-human Primates. Journal of neuromuscular diseases. vol 3. issue 3. 2018-03-15. PMID:27854228. phosphorodiamidate morpholino oligomers (pmos) are a class of exon skipping drugs including eteplirsen, which has shown considerable promise for treatment of the degenerative neuromuscular disease, duchenne musculardystrophy (dmd). 2018-03-15 2023-08-13 Not clear
Jane Larkindale, John D Porte. Seeking a better landscape for therapy development in neuromuscular disorders. Muscle & nerve. vol 57. issue 1. 2017-12-12. PMID:28881009. we discuss a data-sharing model implemented for dmd and urge cultural changes in the ways natural history and clinical trial data are collected and shared across all neuromuscular diseases in order to benefit the primary stakeholder, the patient. 2017-12-12 2023-08-13 Not clear
Suriyan Ponnusamy, Ryan D Sullivan, Dahui You, Nadeem Zafar, Chuan He Yang, Thirumagal Thiyagarajan, Daniel L Johnson, Maron L Barrett, Nikki J Koehler, Mayra Star, Erin J Stephenson, Dave Bridges, Stephania A Cormier, Lawrence M Pfeffer, Ramesh Narayana. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy. Human molecular genetics. vol 26. issue 13. 2017-10-31. PMID:28453658. duchenne muscular dystrophy (dmd) is a neuromuscular disease that predominantly affects boys as a result of mutation(s) in the dystrophin gene. 2017-10-31 2023-08-13 mouse
Andrea M Reinig, Sara Mirzaei, Daniel J Berla. Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging Pharmacotherapies. Pharmacotherapy. vol 37. issue 4. 2017-10-04. PMID:28152217. duchenne muscular dystrophy (dmd) is a genetic neuromuscular disease that primarily affects young males. 2017-10-04 2023-08-13 Not clear
Reiko Shimizu, Katsuhisa Ogata, Akemi Tamaura, En Kimura, Maki Ohata, Eri Takeshita, Harumasa Nakamura, Shin'ichi Takeda, Hirofumi Komak. Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network. BMC health services research. vol 16. 2017-09-28. PMID:27401940. duchenne muscular dystrophy (dmd) is the most commonly inherited neuromuscular disease. 2017-09-28 2023-08-13 Not clear
Christiane Otto, Birgit F Steffensen, Ann-Lisbeth Højberg, Claus Barkmann, Jes Rahbek, Ulrike Ravens-Sieberer, Annette Mahoney, Julia Vry, Kathrin Gramsch, Rachel Thompson, Sunil Rodger, Kate Bushby, Hanns Lochmüller, Janbernd Kirschne. Predictors of Health-Related Quality of Life in boys with Duchenne muscular dystrophy from six European countries. Journal of neurology. vol 264. issue 4. 2017-07-11. PMID:28175989. duchenne muscular dystrophy (dmd) is a progressive, genetically determined neuromuscular disease that affects males and leads to severe physical disability in early teenage years. 2017-07-11 2023-08-13 Not clear
Erik Landfeldt, Peter Lindgren, Christopher F Bell, Michela Guglieri, Volker Straub, Hanns Lochmüller, Katharine Bushb. Quantifying the burden of caregiving in Duchenne muscular dystrophy. Journal of neurology. vol 263. issue 5. 2017-04-04. PMID:26964543. duchenne muscular dystrophy (dmd) is a rare pediatric neuromuscular disease associated with progressive muscle degeneration and extensive care needs. 2017-04-04 2023-08-13 Not clear
Özlem Özmete, Mesut Şener, Esra Çalışkan, Anış Arıboğa. [Application of spinal anesthesia in a pediatric patient with Duchenne's muscular dystrophy]. Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology. vol 28. issue 2. 2017-03-31. PMID:27225742. duchenne's muscular dystrophy (dmd) is a neuromuscular disease with a progressive course. 2017-03-31 2023-08-13 Not clear
Mareike Burow, Raimund Forst, Jürgen Forst, Benjamin Hofner, Albert Fuja. Perioperative complications of scoliosis surgery in patients with Duchenne muscular dystrophy and spinal muscular atrophy, focussing on wound healing disorders. The International journal of neuroscience. vol 127. issue 6. 2017-03-28. PMID:27251216. patients with duchenne muscular dystrophy (dmd) or spinal muscular atrophy (sma), both neuromuscular diseases, sustain spinal scoliosis in the course of their disease. 2017-03-28 2023-08-13 Not clear
Maryam Haghshenas, Mohammad Taghi Akbari, Shohreh Zare Karizi, Faravareh Khordadpoor Deilamani, Shahriar Nafissi, Zivar Saleh. Evaluation of point mutations in dystrophin gene in Iranian Duchenne and Becker muscular dystrophy patients: introducing three novel variants. Journal of genetics. vol 95. issue 2. 2017-03-28. PMID:27350676. duchenne and becker muscular dystrophies (dmd and bmd) are x-linked neuromuscular diseases characterized by progressive muscular weakness and degeneration of skeletal muscles. 2017-03-28 2023-08-13 Not clear
Stijn Oonk, Pietro Spitali, Monika Hiller, Linda Switzar, Hans Dalebout, Mattia Calissano, Hanns Lochmüller, Annemieke Aartsma-Rus, Peter A C 't Hoen, Yuri E M van der Burg. Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients. Proteomics. Clinical applications. vol 10. issue 3. 2017-01-09. PMID:26680509. duchenne muscular dystrophy (dmd) is a severe and fatal neuromuscular disease. 2017-01-09 2023-08-13 Not clear
Cara A Timpani, Alan Hayes, Emma Rybalk. Revisiting the dystrophin-ATP connection: How half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology. Medical hypotheses. vol 85. issue 6. 2016-10-05. PMID:26365249. duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease that is characterised by dystrophin-deficiency and chronic ca(2+)-induced skeletal muscle wasting, which currently has no cure. 2016-10-05 2023-08-13 Not clear
J Fagoaga, M Girabent-Farres, C Bagur-Calafat, B F Steffense. [Evolution of functional capacity, assessed with the Egen Klassifikation scale, in the Spanish population with spinal muscular atrophy or Duchenne muscular dystrophy. A three year longitudinal study]. Revista de neurologia. vol 61. issue 8. 2016-08-31. PMID:26461127. spinal muscular atrophy (sma) and duchenne muscular dystrophy (dmd) are two neuromuscular diseases which evolve with a progressive loss of muscle strength and, therefore, the loss of functional capacity. 2016-08-31 2023-08-13 Not clear
Pam M Van Ry, Ryan D Wuebbles, Megan Key, Dean J Burki. Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy. Molecular therapy : the journal of the American Society of Gene Therapy. vol 23. issue 8. 2016-05-10. PMID:26050991. duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease caused by mutations in the dystrophin gene, leading to the loss of a critical component of the sarcolemmal dystrophin glycoprotein complex. 2016-05-10 2023-08-13 mouse
Claire Latroche, Béatrice Matot, Aurea Martins-Bach, David Briand, Bénédicte Chazaud, Claire Wary, Pierre G Carlier, Fabrice Chrétien, Grégory Jouvio. Structural and Functional Alterations of Skeletal Muscle Microvasculature in Dystrophin-Deficient mdx Mice. The American journal of pathology. vol 185. issue 9. 2016-05-10. PMID:26193666. duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease, caused by an absence of dystrophin, inevitably leading to death. 2016-05-10 2023-08-13 mouse